HealixGlobal is one of the first media agencies to formally join POC3. “By aligning the challenges and goals representative of agencies and pharmaceutical companies with the key players and vendors in the point of care market, it ensures the industry will thrive in a way that is most beneficial to patients and physicians.”
We are honored and humbled to be named a 2018 Innovative Company by PM360 Magazine. As Jeffrey Erb said in our acceptance speech, it is the drive and passion of our people that makes us the innovative group that we are.
Thank you PM360 for this amazing recognition of our team.
Video has transformed online engagement across brands throughout almost every industry, and new approaches to content and delivery are poised to transform pharmaceutical media. According to AdWeek, pharma brands receive more shares and comments per video than any other type of content, and generally speaking, the market for online video is growing at an incredibly rapid rate. Forrester estimates that online video ads will grow from about 21% of the market in 2018 to 34% in 2023, rising alongside the amount of time consumers will spend watching streaming video…
In this month’s PM360, Jeffrey Erb discusses the opportunities and challenges engaging audeinces through video pose in the industry. Read the article.
Jeffrey Erb, president, HealixGlobal, was named to the Top 50 Health Influencer list compiled by MM&M and PRWeek.
As president of IPG media firm Healix, Jeffrey Erb understands how the pharma advertising world is changing and what opportunities that presents.
“What I find exciting about the industry is that it’s going through a significant amount of change,” he said in August.“What we do is really push people out of their comfort zone. We’re constantly looking at things differently and figuring out ways to evolve with the way the world is evolving and that is where you find your agency’s differentiation.”
As the industry changes, it gives healthcare agencies the chance to push boundaries in a sector that is traditionally more conservative, Erb said. He is also actively trying to make the industry better, helping form a consortium for media buyers in the point-of-care sector.
He has led Healix since April 2016. Before that, his career jumped between film production companies and marketing firms.
On the marketing side, Erb has recently worked at Digital Brand Expressions, Alliance Life Sciences, and Harte-Hanks, among others. He has also cofounded two production studios, Ironbound Studios Minnesota and Framelight.
For the list of Top 50 Health Influencers, click here.
Jeffrey D. Erb, has created a culture of innovation at HealixGlobal — status quo is not in our vocabulary. He constantly encourages his team to look for ways to adjust our thinking and that of our clients to break down barriers and expand the reach of our clients’ brands.
Jeff is changing healthcare media buying with the incorporation of psychological and behavioral data to improve targeting and engagement – something that has been elusive in this highly regulated industry. He is responsible for organizing this move to bring unprecedented levels of qualitative and quantitative analytics to the forefront of the creative planning process through the development of Healix’s proprietary analytics tool, DNA. DNA allows us to layer traditional qualitative marketing data with the psychology of human qualitative engagement and allow us to see not only the what, where, when and how people engage with a communication program, but also the “why” people engage the way they do — all anonymously and within HIPAA guidelines. This gives brands a tool to better understand how their messages are driving openness to recommendations and, ultimately, scripts.
Jeff was honored at the awards reception held October 9 at the 2018 DTC Forum on Social Media & Technology.
For a list of all honorees, click here.